Sign up for news & promotions:
ProMab Presents Promising Results in Humanized CD19 CAR-T Cells Trial
July 28, 2020
ProMab Bispecific Antibody Webinar
June 2, 2021
ProMab Biotechnologies is the world’s first CRO committed to improving human health with a focus on immunotherapy, specifically CAR-T/NK cell technologies. Production of CAR-T cells with proper qualities is essential for CAR-T success in vivo. In this webinar for scientists, physicians and patients, Robert Berahovich, Ph.D., of ProMab, discusses CAR-T cell generation for preclinical studies.
- Speakers: Evelin Szakal, PhD, and Robert Berahovich PhD, ProMab Biotechnologies
- Date: Oct 28th, 2020, Wednesday
- Time: 11 AM PDT | 2 PM EDT
Share